233 related articles for article (PubMed ID: 20622039)
41. Troglitazone upregulates PTEN expression and induces the apoptosis of pulmonary artery smooth muscle cells under hypoxic conditions.
Pi WF; Guo XJ; Su LP; Xu WG
Int J Mol Med; 2013 Nov; 32(5):1101-9. PubMed ID: 24026200
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of Selexipag [corrected] and prostacyclin analogs in rat pulmonary artery.
Morrison K; Studer R; Ernst R; Haag F; Kauser K; Clozel M
J Pharmacol Exp Ther; 2012 Dec; 343(3):547-55. PubMed ID: 22918043
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological activation of PPARγ inhibits hypoxia-induced proliferation through a caveolin-1-targeted and -dependent mechanism in PASMCs.
Yang K; Zhao M; Huang J; Zhang C; Zheng Q; Chen Y; Jiang H; Lu W; Wang J
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C428-C438. PubMed ID: 29351409
[TBL] [Abstract][Full Text] [Related]
44. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
[TBL] [Abstract][Full Text] [Related]
45. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
46. IL-1beta, BK, and TGF-beta1 attenuate PGI2-mediated cAMP formation in human pulmonary artery smooth muscle cells by multiple mechanisms involving p38 MAP kinase and PKA.
El-Haroun H; Clarke DL; Deacon K; Bradbury D; Clayton A; Sutcliffe A; Knox AJ
Am J Physiol Lung Cell Mol Physiol; 2008 Mar; 294(3):L553-62. PubMed ID: 18156442
[TBL] [Abstract][Full Text] [Related]
47. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
[TBL] [Abstract][Full Text] [Related]
48. Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.
Nisbet RE; Bland JM; Kleinhenz DJ; Mitchell PO; Walp ER; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2010 Apr; 42(4):482-90. PubMed ID: 19520921
[TBL] [Abstract][Full Text] [Related]
49. Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.
Ahn JH; Lee KT; Choi YS; Choi JH
Prostaglandins Other Lipid Mediat; 2018 Jan; 134():47-56. PubMed ID: 29292033
[TBL] [Abstract][Full Text] [Related]
50. Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs.
Schermuly RT; Pullamsetti SS; Breitenbach SC; Weissmann N; Ghofrani HA; Grimminger F; Nilius SM; Schrör K; Kirchrath JM; Seeger W; Rose F
Respir Res; 2007 Jan; 8(1):4. PubMed ID: 17257398
[TBL] [Abstract][Full Text] [Related]
51. A long-acting and highly selective prostacyclin receptor agonist prodrug, 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), ameliorates rat pulmonary hypertension with unique relaxant responses of its active form, {4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}acetic acid (MRE-269), on rat pulmonary artery.
Kuwano K; Hashino A; Noda K; Kosugi K; Kuwabara K
J Pharmacol Exp Ther; 2008 Sep; 326(3):691-9. PubMed ID: 18552131
[TBL] [Abstract][Full Text] [Related]
52. Prostacyclin is an autocrine regulator in the contraction of oviductal smooth muscle.
Arbab F; Goldsby J; Matijevic-Aleksic N; Huang G; Ruan KH; Huang JC
Hum Reprod; 2002 Dec; 17(12):3053-9. PubMed ID: 12456602
[TBL] [Abstract][Full Text] [Related]
53. Peroxisome Proliferator-Activated Receptor γ-Mediated Inhibition on Hypoxia-Triggered Store-Operated Calcium Entry. A Caveolin-1-Dependent Mechanism.
Yang K; Lu W; Jiang Q; Yun X; Zhao M; Jiang H; Wang J
Am J Respir Cell Mol Biol; 2015 Dec; 53(6):882-92. PubMed ID: 26020612
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells.
Pape R; Rauch BH; Rosenkranz AC; Kaber G; Schrör K
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):534-40. PubMed ID: 18162607
[TBL] [Abstract][Full Text] [Related]
55. Phosphodiesterase 5 inhibitors augment UT-15C-stimulated ATP release from erythrocytes of humans with pulmonary arterial hypertension.
Bowles EA; Moody GN; Yeragunta Y; Stephenson AH; Ellsworth ML; Sprague RS
Exp Biol Med (Maywood); 2015 Jan; 240(1):121-7. PubMed ID: 25125498
[TBL] [Abstract][Full Text] [Related]
56. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
[TBL] [Abstract][Full Text] [Related]
57. Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats.
Zhang D; Wang G; Han D; Zhang Y; Xu J; Lu J; Li S; Xie X; Liu L; Dong L; Li M
Life Sci; 2014 Mar; 98(1):39-43. PubMed ID: 24412385
[TBL] [Abstract][Full Text] [Related]
58. Cathepsin S promotes the development of pulmonary arterial hypertension.
Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
[TBL] [Abstract][Full Text] [Related]
59. Selexipag: a selective prostacyclin receptor agonist that does not affect rat gastric function.
Morrison K; Ernst R; Hess P; Studer R; Clozel M
J Pharmacol Exp Ther; 2010 Oct; 335(1):249-55. PubMed ID: 20660124
[TBL] [Abstract][Full Text] [Related]
60. Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous.
Perros F; Sentenac P; Boulate D; Manaud G; Kotsimbos T; Lecerf F; Lamrani L; Fadel E; Mercier O; Londono-Vallejo A; Humbert M; Eddahibi S
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
